Product
Mifamurtide
2 clinical trials
1 indication
Indication
OsteosarcomaClinical trial
Multicentre, Randomised, Phase 2 Trial of Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (Metastatic Osteosarcoma at Diagnosis or Localised Disease With Poor Histological Response)Status: Active (not recruiting), Estimated PCD: 2024-10-01
Clinical trial
ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma - Prospective Study (ISG/OS-2)Status: Completed, Estimated PCD: 2024-04-30